47,95 €
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
24 °P sammeln
47,95 €
47,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
24 °P sammeln
Als Download kaufen
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
24 °P sammeln
Jetzt verschenken
47,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
24 °P sammeln
  • Format: ePub

This book provides up-to-date, evidence-based and unbiased information about psychopharmacology. It spans the range of the discipline, from mode of action and side effects of drugs to meta-analyses of clinical trials. This latest edition is fully updated and provides the key facts about currently used psychotropic drugs, set in the context of the neuroscience of the disorders they treat. It also includes a new chapter on the principles of psychiatric prescribing. Key references are provided at the end of each chapter along with suggestions for further reading.

  • Geräte: eReader
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 2.76MB
Produktbeschreibung
This book provides up-to-date, evidence-based and unbiased information about psychopharmacology. It spans the range of the discipline, from mode of action and side effects of drugs to meta-analyses of clinical trials. This latest edition is fully updated and provides the key facts about currently used psychotropic drugs, set in the context of the neuroscience of the disorders they treat. It also includes a new chapter on the principles of psychiatric prescribing. Key references are provided at the end of each chapter along with suggestions for further reading.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Edited by

Ian M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP.

R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.